Original Article

Heparin-Induced Thrombocytopenia in Iranian Cardiac Surgery Patients Using the 4Ts Clinical Scoring System and Laboratory Methods

Abstract

Background: Heparin-induced thrombocytopenia (HIT) is a serious adverse drug reaction. HIT diagnosis needs an algorithmic approach including clinical evaluation and laboratory tests (screening and confirmatory). Few studies have been conducted on HIT in Iran, and most existing research has been general and based on clinical evaluations alone. The present study was conducted to determine the prevalence of HIT among cardiac surgery patients using an algorithmic approach.

Materials and Methods: A cross-sectional study was carried out over a period of 10 months, at Modares Hospital (Tehran, Iran) on 92 patients who were candidates for cardiac surgery. For the clinical evaluation, the 4Ts scoring system was used; in cases with 4Ts scores ≥4, a laboratory evaluation of anti-PF4/heparin antibody (Ab) was performed by enzyme-linked immunosorbent assay (ELISA) and a HIPA test too as a functional confirmatory method. The patients with 4Ts scores ≥4 who were ELISA positive (OD ≥0.2) and HIPA positive were taken as a definite case of HIT.

Results: Of the 92 patients who had undergone cardiac surgery, 14 (15%) had 4Ts scores ≥4. Anti- PF4/heparin Ab was detected in eight patients using the ELISA and in six patients using the HIPA. Ultimately, definite HIT was confirmed in five of the patients.

Conclusion: The prevalence of HIT was 5.4% among the cardiac surgery patients assessed in the present study. To the researchers’ knowledge, this is the first time that HIT has been evaluated in Iran using a comprehensive algorithmic approach including clinical history-taking and both immunological and functional laboratory tests, and the findings showed a slightly higher HIT frequency in this single-center study in comparison with the other studies carried out in other countries.

 

1. Demma LJ, Winkler AM, Levy JH. Diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Anesth Analg. 2011; 113(4): 697-702.
2. Assmann A, Boeken u, Feindt P, et al. Heparin-induced thrombocytopenia type II after cardiac surgery: predictors and outcome. Thorac Cardiovasc Surg. 2010; 58(8): 463-7.
3. Greinacher A. Heparin-Induced Thrombocytopenia. N Engl J Med. 2015; 373(19): 1883-4.
4. Levy JH , Winkler AM. Heparin-induced thrombocytopenia and cardiac surgery. Curr Opin Anaesthesiol. 2010; 23(1): 74-9.
5. Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018; 2(22): 3360-3392.
6. Pishko AM , Cuker A. Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients. Semin Thromb Hemost. 2017; 43(7): 691-698.
7. Selleng S, Malowsky B, Strobel U, et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2010;8(1): 30-6.
8. Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood. 2012; 119(10): 2209-18.
9. Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost., 2006; 4(4): 759-65.
10. Favaloro EJ, McCaughan G, Pasalic L. Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update. Pathology. 2017; 49(4): 346-355.
11. Nagler M, Bakchoul T. Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 2016; 116(5): 823-834
12. Favaloro EJ, McCaughan G , Mohammed S, et al. HIT or miss?. A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia. Pathology. 2018; 50(4): 426-436.
13. Minet V, Dogné JM, Mullier F. Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review. Molecules. 2017; 22(4):617.
14. Warkentin TE, Arnold DM , Nazi I, et al. The platelet serotonin-release assay. Am J Hematol. 2015; 90(6): 564-72.
15. Beigmohammadi MB, Khan ZH, Khalili H. Enoxaparin in suspected heparin induced thrombocytopenia: an observational follow-up in critically ill patients. Biomed J Sci &Tec Res. 2018; 3(3):3330-3334.
16. Foroughinia F, Farsad F, Gholam KH, et al. Usefulness of Danaparoid sodium in patients with Heparin-induced thrombocytopenia after cardiac surgery. J Res Pharm Pract. 2015; 4(2): 73-8.
17. Nasiripour S, Saif M, Farasatinasab M, et al. Dabigatran as a Treatment Option for Heparin-Induced Thrombocytopenia. J Clin Pharmacol. 2019; 59(1): 107-111.
18. Aguayo E, Sanaiha Y, Seo YJ, et al. Heparin-induced thrombocytopenia in cardiac surgery: Incidence, costs, and duration of stay. Surgery. 2018; 164(6): 1377-1381.
19. Arepally GM , Orte TLl. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006; 355(8): 809-17.
20. Lee GM, Arepally GM. Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2013; 27(3): 541-63.
21. Warkentin TE, Sheppard JOI, Sigouin CS, et al. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006; 108(9): 2937-41.
22. Piednoir P, Allou N, Provenchère S, et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth. 2012; 26(4): 585-90.
23. Solanki J, Shenoy S , Downs E, et al. Heparin-Induced Thrombocytopenia and Cardiac Surgery. Semin Thorac Cardiovasc Surg. 2019; 31(3):335-344.
24. Motie MR, Kazemzadeh G, Gazeran S. Comparing the incidence of heparin-induced thrombocytopenia (HIT) in patients receiving heparin (UHF) and enoxaparin LMWH.Biomed Res. 2017; 28(5):6.
25. Sun L, Gimotty PA, Lakshmanan S, et al. Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. Thromb Haemost. 2016; 115(5): 1044-55.
26. Ahmadinejad M. Is it Time to Renew the Guidelines for Diagnosis of HIT? EC Cardiology. 2018; 5: 371-373.
Files
IssueVol 15, No 4 (2021) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijhoscr.v15i4.7478
Keywords
Heparin; Heparin-induced thrombocytopenia (HIT), Diagnosis; Laboratory testing; Cardiac surgery
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ahmadinejad M, Shahbazi M, Chegini A. Heparin-Induced Thrombocytopenia in Iranian Cardiac Surgery Patients Using the 4Ts Clinical Scoring System and Laboratory Methods. Int J Hematol Oncol Stem Cell Res. 2021;15(4):230-238.